Caudill Cortney bought HALO

March 9, 2026 · Form 4 insider transaction

Caudill Cortney bought 20,000 shares of Halozyme Therapeutics, Inc. at $33.51 per share, a transaction worth $670.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.